Collar Capital Management LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 12,590 shares of the healthcare conglomerate’s stock, valued at approximately $4,347,000. UnitedHealth Group comprises approximately 3.1% of Collar Capital Management LLC’s investment portfolio, making the stock its 6th biggest holding.
A number of other hedge funds have also bought and sold shares of UNH. Murphy Pohlad Asset Management LLC grew its stake in UnitedHealth Group by 21.8% in the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after acquiring an additional 791 shares in the last quarter. Berkshire Hathaway Inc bought a new position in UnitedHealth Group in the second quarter worth approximately $1,572,193,000. Triumph Capital Management bought a new stake in UnitedHealth Group during the 2nd quarter valued at $1,324,000. Wealth Effects LLC grew its position in shares of UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after buying an additional 591 shares in the last quarter. Finally, IFP Advisors Inc raised its holdings in shares of UnitedHealth Group by 20.7% in the second quarter. IFP Advisors Inc now owns 20,683 shares of the healthcare conglomerate’s stock valued at $6,462,000 after acquiring an additional 3,545 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have recently commented on UNH. Bank of America boosted their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. TD Cowen upped their target price on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a report on Thursday, October 30th. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. UBS Group lifted their target price on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Finally, The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price target on the stock. Seventeen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $385.54.
UnitedHealth Group Stock Up 0.7%
NYSE:UNH opened at $327.08 on Friday. The company’s 50 day moving average is $334.20 and its two-hundred day moving average is $318.80. The company has a market cap of $296.28 billion, a PE ratio of 17.07, a P/E/G ratio of 2.13 and a beta of 0.43. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $7.15 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. UnitedHealth Group’s payout ratio is 46.14%.
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
See Also
- Five stocks we like better than UnitedHealth Group
- Turn your “dead money” into $306+ monthly (starting this month)
- Washington prepares for war
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- The McDonald’s Secret
- 33,000% boom from weird new “AI Fuel?”
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
